GA-map Dysbiosis Test Kit Available on Luminex’s Multiplexing Platform
Microbiome DX company Genetic Analysis AS completed the development and CE-marking of the GA-map Dysbiosis Test for the Luminex MAGPIX instrument system.
Read MorePosted by Andy Lundin | Feb 7, 2022 | Microarray Systems |
Microbiome DX company Genetic Analysis AS completed the development and CE-marking of the GA-map Dysbiosis Test for the Luminex MAGPIX instrument system.
Read MorePosted by Andy Lundin | Feb 7, 2022 | Accreditation |
Clinical diagnostic lab company Artemis DNA received an accreditation from the College of American Pathologists (CAP) for its Irvine, California facility.
Read MorePosted by Andy Lundin | Jan 27, 2022 | Covid 19 |
A resource that scientists have used for tracking large-scale COVID patterns—amid the surge of new variant infections—is the wastewater system.
Read MorePosted by Andy Lundin | Jan 26, 2022 | Covid 19, POC Reagents & Test Kits |
Researchers have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests.
Read MorePosted by Andy Lundin | Jan 25, 2022 | Molecular Diagnostics |
A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable, and scalable, recent research shows.
Read More